Pulmonary Mycobacterium abscessus: A canary in the cystic fibrosis coalmine

Journal of Infection

Volumn 64, Issue 6, 2012, Pages 609-612

  Haverkamp, Margje H ^a   van Wengen, Annelies ^a   de Visser, Adriëtte W ^a   van Kralingen, Klaas W ^a   van Dissel, Jaap T ^a   van de Vosse, Esther ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atypical mycobacteria; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Mendelian susceptibility to mycobacterial disease; Mycobacterium abscessus

Indexed keywords

AMIKACIN; AMOXICILLIN; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; COTRIMOXAZOLE; CYCLOSERINE; DOXYCYCLINE; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; MEROPENEM; PROTIONAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADD ON THERAPY; ADULT; ADULTHOOD; ANTIBIOTIC RESISTANCE; ARTICLE; CACHEXIA; CANARY; CASE REPORT; COAL MINING; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; GENE DELETION; GENE MUTATION; HAEMOPHILUS INFECTION; HETEROZYGOSITY; HOST; HUMAN; LABORATORY TEST; LUNG INFECTION; MEDICAL HISTORY; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; NIGHT SWEAT; PATIENT REFERRAL; PHENOTYPE; PHYSICAL EXAMINATION; SPUTUM CULTURE; SYMPTOM; TREATMENT OUTCOME;

ADULT; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; HETEROZYGOTE; HUMANS; LUNG ABSCESS; MUTATION, MISSENSE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; SEQUENCE DELETION;

EID: 84860604993     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.02.010     Document Type: Article

References (11)

1. De Groote M.A., Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis 2006, 42:1756-1763.
2. Ziedalski T.M., Kao P.N., Henig N.R., Jacobs S.S., Ruoss S.J. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest 2006, 130:995-1002.
3. Olivier K.N., Weber D.J., Wallace R.J., Faiz A.R., Lee J.-H., Zhang Y., et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003, 167:828-834. Nontuberculous Mycobacteria in Cystic Fibrosis Study Group.
4. Lichtenauer-Kaligis E.G.R., de Boer T., Verreck F.A.W., van Voorden S., Hoeve M.A., van de Vosse E., et al. Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor β1 deficient patients and evidence for the existence of partial IL-12 receptor β1 deficiency. Eur J Immunol 2003, 33:59-69.
5. Massie R.J.H., Poplawski N., Wilcken B., Goldblatt J., Byrnes C., Robertson C. Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C. Eur Respir J 2001, 17:1195-1200.
6. Gilljam M., Scherstén H., Siverborn M., Jonsson B., Ericsson Hollsing A. Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection. J Cyst Fibros 2010, 9:272-276.
7. Thauvin-Robinet C., Munck A., Huet F., Génin E., Bellis G., Gautier E., et al. The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counseling and newborn screening. J Med Genet 2009, 46:752-758. Collaborating Working Group on R117H.
8. Rosenstein B.J., Cutting G.R. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998, 132:589-595.
9. Van de Vosse E., van Dissel J.T., Ottenhof T.H.M. Genetic deficiencies of innate immune signaling in human infectious disease. Lancet Infect Dis 2009, 9:688-698.
10. Iseman M.D., Buschman D.L., Ackerson L.M. Pectus excavatum and scoliosis. Am Rev Respir Dis 1991, 144:914-916.
11. Kim R.D., Greenberg D.E., Ehrmantraut M.E., Guide S.V., Ding L., Shea Y., et al. Pulmonary nontuberculous mycobacterial disease. Prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 2008, 178:1066-1074.